BOSCH MARNIX LEO,GANJEI JAMES KELLY,POWERS LINDA F,LIAU LINDA M,PRINS ROBERT M
申请号：
IN201627015553
公开号：
IN201627015553A
申请日:
2016.05.04
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
The present disclosure arises at least in part from the seminal recognition that a combination treatment regimen including one or more cycles and/or doses of a checkpoint inhibitor and a therapeutic either sequentially in either order or substantially simultaneously can be more effective in treating cancer in some subjects and/or can initiate enable increase enhance or prolong the activity and/or number of immune cells or a medically beneficial response by a tumor.
